Companion Diagnostics Development
Various
Pre-clinicalActive
Key Facts
About Kiffik Biomedical
Kiffik Biomedical is an early-stage diagnostics company pioneering a novel platform for continuous, non-invasive biomarker monitoring from interstitial fluid (ISF). Its core technology, KIFFIK EXP, is a wearable device that captures molecular data not readily available in blood, targeting applications in clinical trial optimization, companion diagnostics, and remote patient monitoring. The company is currently in the investigational stage, partnering with pharmaceutical and diagnostic leaders to validate its platform across multiple therapeutic areas, including oncology, women's health, and military medicine.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| New TCM Formula Registration | Universe Pharmaceuticals | Development |
| CBD/THC Oil Formulation | Avecho Biotechnology | Preclinical |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Portfolio of 40+ products | Praxgen Pharmaceuticals | Development |
| Drug Repositioning Service | Biovista | Service |
| Custom Control Development | Anchor Molecular | Development/Commercial |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |
| Generic Medicinal Products Development | Basic Pharma | Commercial |